Mexico has become a testing ground for psychedelic therapies – The Economist

Try our new AI-powered search

beta
Olivia has suffered with depression and struggled to form romantic attachments ever since she was sexually assaulted. Counselling and medication scarcely helped. So in September 2023 she flew to Mexico and joined a retreat that uses 5-MeODMT, a psychedelic compound, as a therapeutic agent. She was “terrified”, but says the drug was “an opening” and that it let her body “feel what it needed to feel to start processing” her assault. She plans to return to Mexico for more psychedelic therapy this year.
Indigenous people across Latin America have long used naturally occurring psychedelics. As a result, they tend to be legal and easy to obtain in the region, not banned as they are in the United States. After Life magazine published an article in 1957 by Gordon Wasson, an amateur botanist, about his experience taking magic mushrooms in Mexico, hippies and rockstars flocked there. Now growing numbers of people like Olivia (not her real name) are coming to use psychedelics therapeutically rather than recreationally. Lysergic acid diethylamide (LSD) is the best known, but the category includes 5-MeODMT (which can be synthesised but is also found in a toad and plants), psilocybin (found in mushrooms), mescaline (cactus) and DMT (found in ayahuasca, a drink brewed from a South American vine).
This article appeared in the The Americas section of the print edition under the headline “A different kind of help”
Discover stories from this section and more in the list of contents
Paraguay has benefited from increased Taiwanese investment, but will it be enough to ward off the lure of Beijing?
The region’s leaders are failing to consider the risks of growing dependence
So-called harm-reduction measures have become a rod for Justin Trudeau’s back
Paraguay has benefited from increased Taiwanese investment, but will it be enough to ward off the lure of Beijing?
The region’s leaders are failing to consider the risks of growing dependence
So-called harm-reduction measures have become a rod for Justin Trudeau’s back
But can it make a difference?
The sight of armoured vehicles ramming the presidential palace will scare investors away
But the biggest economic test is yet to come
Published since September 1843 to take part in “a severe contest between intelligence, which presses forward, and an unworthy, timid ignorance obstructing our progress.”
To enhance your experience and ensure our website runs smoothly, we use cookies and similar technologies.
Copyright © The Economist Newspaper Limited 2024. All rights reserved.

source

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *